CLINICAL STUDY: ELECTROPHYSIOLOGY
A comparison of T-wave alternans, signal averaged electrocardiography and programmed ventricular stimulation for arrhythmia risk stratification
Michael R. Gold, MD, PhD, FACC*,
Daniel M. Bloomfield, MD, FACC ,
Kelley P. Anderson, MD, FACC ,
Nabil E. El-Sherif, MD, FACC ,
David J. Wilber, MD, FACC||,
William J. Groh, MD, FACC ,
N. A. Mark Estes, III, MD, FACC#,
Elizabeth S. Kaufman, MD, FACC ,
Mark L. Greenberg, MD, FACC** and
David S. Rosenbaum, MD, FACC**
* Department of Medicine, Division of Cardiology, University of Maryland Medical System, Baltimore, Maryland, USA
Columbia Presbyterian Medical Center, New York, New York, USA
University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania, USA
Veterans Affairs Medical Center, Brooklyn, New York, USA
|| University of Chicago Hospitals, Chicago, Illinois, USA
# New England Medical Center, Boston, Massachusetts, USA
** MetroHealth Campus, Case Western Reserve University, Cleveland, Ohio, USA
 Dartmouth Hitchcock Medical Center, Lebanon, New Hampshire, USA
Manuscript received February 22, 2000;
revised manuscript received August 2, 2000,
accepted August 11, 2000.
Reprint requests and correspondence: Dr. Michael R. Gold, Division of Cardiology, N3W77, University of Maryland Medical System, 22 South Greene Street, Baltimore, Maryland 21201 MGold{at}medicine.umaryland.edu
OBJECTIVES
The goal of this study was to compare T-wave alternans (TWA), signal-averaged electrocardiography (SAECG) and programmed ventricular stimulation (EPS) for arrhythmia risk stratification in patients undergoing electrophysiology study.
BACKGROUND
Accurate identification of patients at increased risk for sustained ventricular arrhythmias is critical to prevent sudden cardiac death. T-wave alternans is a heart rate dependent measure of repolarization that correlates with arrhythmia vulnerability in animal and human studies. Signal-averaged electrocardiography and EPS are more established tests used for risk stratification.
METHODS
This was a prospective, multicenter trial of 313 patients in sinus rhythm who were undergoing electrophysiologic study. T-wave alternans, assessed with bicycle ergometry, and SAECG were measured before EPS. The primary end point was sudden cardiac death, sustained ventricular tachycardia, ventricular fibrillation or appropriate implantable defibrillator (ICD) therapy, and the secondary end point was any of these arrhythmias or all-cause mortality.
RESULTS
Kaplan-Meier survival analysis of the primary end point showed that TWA predicted events with a relative risk of 10.9, EPS had a relative risk of 7.1 and SAECG had a relative risk of 4.5. The relative risks for the secondary end point were 13.9, 4.7 and 3.3, respectively (p < 0.05). Multivariate analysis of 11 clinical parameters identified only TWA and EPS as independent predictors of events. In the prespecified subgroup with known or suspected ventricular arrhythmias, TWA predicted primary end points with a relative risk of 6.1 and secondary end points with a relative risk of 8.0.
CONCLUSIONS
T-wave alternans is a strong independent predictor of spontaneous ventricular arrhythmias or death. It performed as well as programmed stimulation and better than SAECG in risk stratifying patients for life-threatening arrhythmias.
|
Abbreviations and Acronyms
| | EPS | = programmed ventricular stimulation during electrophysiology study | | ICD | = implantable cardioverter-defibrillator | | SAECG | = signal averaged electrocardiogram | | TWA | = T-wave alternans | | VTE | = ventricular tachyarrhythmic event |
|
This article has been cited by other articles:

|
 |

|
 |
 
K. C. van den Broek, I. Nyklicek, P. H. van der Voort, M. Alings, A. Meijer, and J. Denollet
Risk of ventricular arrhythmia after implantable defibrillator treatment in anxious type D patients.
J. Am. Coll. Cardiol.,
August 4, 2009;
54(6):
531 - 537.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E. J. Rashba
Anger management may save your life new insights into emotional precipitants of ventricular arrhythmias.
J. Am. Coll. Cardiol.,
March 3, 2009;
53(9):
779 - 781.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. R. Gold, J. H. Ip, O. Costantini, J. E. Poole, S. McNulty, D. B. Mark, K. L. Lee, and G. H. Bardy
Role of Microvolt T-Wave Alternans in Assessment of Arrhythmia Vulnerability Among Patients With Heart Failure and Systolic Dysfunction: Primary Results From the T-Wave Alternans Sudden Cardiac Death in Heart Failure Trial Substudy
Circulation,
November 11, 2008;
118(20):
2022 - 2028.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. J. Goldberger, M. E. Cain, S. H. Hohnloser, A. H. Kadish, B. P. Knight, M. S. Lauer, B. J. Maron, R. L. Page, R. S. Passman, D. Siscovick, et al.
American Heart Association/American College of Cardiology Foundation/Heart Rhythm Society Scientific Statement on Noninvasive Risk Stratification Techniques for Identifying Patients at Risk for Sudden Cardiac Death: A Scientific Statement From the American Heart Association Council on Clinical Cardiology Committee on Electrocardiography and Arrhythmias and Council on Epidemiology and Prevention
J. Am. Coll. Cardiol.,
September 30, 2008;
52(14):
1179 - 1199.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. J. Goldberger, M. E. Cain, S. H. Hohnloser, A. H. Kadish, B. P. Knight, M. S. Lauer, B. J. Maron, R. L. Page, R. S. Passman, D. Siscovick, et al.
American Heart Association/American College of Cardiology Foundation/Heart Rhythm Society Scientific Statement on Noninvasive Risk Stratification Techniques for Identifying Patients at Risk for Sudden Cardiac Death: A Scientific Statement From the American Heart Association Council on Clinical Cardiology Committee on Electrocardiography and Arrhythmias and Council on Epidemiology and Prevention
Circulation,
September 30, 2008;
118(14):
1497 - 1518.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. C. Myles, C. E. Jackson, I. Tsorlalis, M. C. Petrie, J. J. V. McMurray, and S. M. Cobbe
Is Microvolt T-Wave Alternans the Answer to Risk Stratification in Heart Failure?
Circulation,
December 18, 2007;
116(25):
2984 - 2991.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. V. Exner, K. M. Kavanagh, M. P. Slawnych, L. B. Mitchell, D. Ramadan, S. G. Aggarwal, C. Noullett, A. Van Schaik, R. T. Mitchell, M. A. Shibata, et al.
Noninvasive Risk Assessment Early After a Myocardial Infarction: The REFINE Study
J. Am. Coll. Cardiol.,
December 11, 2007;
50(24):
2275 - 2284.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. Nieminen, T. Lehtimaki, J. Viik, R. Lehtinen, K. Nikus, T. Koobi, K. Niemela, V. Turjanmaa, W. Kaiser, H. Huhtala, et al.
T-wave alternans predicts mortality in a population undergoing a clinically indicated exercise test
Eur. Heart J.,
October 1, 2007;
28(19):
2332 - 2337.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. P. Anderson
Risk Assessment for Defibrillator Therapy: Il Trittico
J. Am. Coll. Cardiol.,
September 18, 2007;
50(12):
1158 - 1160.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. J. Cantillon, K. M. Stein, S. M. Markowitz, S. Mittal, B. K. Shah, D. P. Morin, E. S. Zacks, M. Janik, S. Ageno, A. C. Mauer, et al.
Predictive Value of Microvolt T-Wave Alternans in Patients With Left Ventricular Dysfunction
J. Am. Coll. Cardiol.,
July 10, 2007;
50(2):
166 - 173.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. M. Russo and F. E. Marchlinski
Should Microvolt T-Wave Alternans Be Utilized Routinely in Selecting Patients for Prophylactic Implantable Cardioverter-Defibrillator Insertion in the Setting of Ischemic Heart Disease?
J. Am. Coll. Cardiol.,
January 2, 2007;
49(1):
59 - 61.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. Ikeda, H. Yoshino, K. Sugi, K. Tanno, H. Shimizu, J. Watanabe, Y. Kasamaki, A. Yoshida, and T. Kato
Predictive Value of Microvolt T-Wave Alternans for Sudden Cardiac Death in Patients With Preserved Cardiac Function After Acute Myocardial Infarction: Results of a Collaborative Cohort Study
J. Am. Coll. Cardiol.,
December 5, 2006;
48(11):
2268 - 2274.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E. S. Kaufman, D. M. Bloomfield, R. C. Steinman, P. B. Namerow, O. Costantini, R. J. Cohen, and J. T. Bigger Jr
"Indeterminate" Microvolt T-Wave Alternans Tests Predict High Risk of Death or Sustained Ventricular Arrhythmias in Patients With Left Ventricular Dysfunction
J. Am. Coll. Cardiol.,
October 3, 2006;
48(7):
1399 - 1404.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Z. Goldberger and R. Lampert
Implantable Cardioverter-Defibrillators: Expanding Indications and Technologies
JAMA,
February 15, 2006;
295(7):
809 - 818.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. M. Bloomfield, J. T. Bigger, R. C. Steinman, P. B. Namerow, M. K. Parides, A. B. Curtis, E. S. Kaufman, J. M. Davidenko, T. S. Shinn, and J. M. Fontaine
Microvolt T-Wave Alternans and the Risk of Death or Sustained Ventricular Arrhythmias in Patients With Left Ventricular Dysfunction
J. Am. Coll. Cardiol.,
January 17, 2006;
47(2):
456 - 463.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. M. Narayan
T-Wave Alternans and the Susceptibility to Ventricular Arrhythmias
J. Am. Coll. Cardiol.,
January 17, 2006;
47(2):
269 - 281.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
V. S. Chauhan, E. Downar, K. Nanthakumar, J. D. Parker, H. J. Ross, W. Chan, and P. Picton
Increased ventricular repolarization heterogeneity in patients with ventricular arrhythmia vulnerability and cardiomyopathy: a human in vivo study
Am J Physiol Heart Circ Physiol,
January 1, 2006;
290(1):
H79 - H86.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
B. Pitt, the EPHESUS Investigators, F. Zijlstra, I. C.C. van der Horst, A. Khera, B. D. Levine, A. G. Jacobs, S. D. Solomon, R. M. Califf, M. A. Pfeffer, et al.
Sudden Death in Patients with Myocardial Infarction
N. Engl. J. Med.,
September 22, 2005;
353(12):
1294 - 1297.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. K. Gehi, R. H. Stein, L. D. Metz, and J. A. Gomes
Microvolt T-Wave Alternans for the Risk Stratification of Ventricular Tachyarrhythmic Events: A Meta-Analysis
J. Am. Coll. Cardiol.,
July 5, 2005;
46(1):
75 - 82.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. C. Haigney, W. Zareba, P. J. Gentlesk, R. E. Goldstein, M. Illovsky, S. McNitt, M. L. Andrews, A. J. Moss, and the MADIT II Investigators
QT interval variability and spontaneous ventricular tachycardia or fibrillation in the Multicenter Automatic Defibrillator Implantation Trial (MADIT) II patients
J. Am. Coll. Cardiol.,
October 6, 2004;
44(7):
1481 - 1487.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. M. Bloomfield, R. C. Steinman, P. B. Namerow, M. Parides, J. Davidenko, E. S. Kaufman, T. Shinn, A. Curtis, J. Fontaine, D. Holmes, et al.
Microvolt T-Wave Alternans Distinguishes Between Patients Likely and Patients Not Likely to Benefit From Implanted Cardiac Defibrillator Therapy: A Solution to the Multicenter Automatic Defibrillator Implantation Trial (MADIT) II Conundrum
Circulation,
October 5, 2004;
110(14):
1885 - 1889.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
W. J. Kop, D. S. Krantz, B. D. Nearing, J. S. Gottdiener, J. F. Quigley, M. O'Callahan, A. A. DelNegro, T. D. Friehling, P. Karasik, S. Suchday, et al.
Effects of Acute Mental Stress and Exercise on T-Wave Alternans in Patients With Implantable Cardioverter Defibrillators and Controls
Circulation,
April 20, 2004;
109(15):
1864 - 1869.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. Tanno, S. Ryu, N. Watanabe, Y. Minoura, M. Kawamura, T. Asano, Y. Kobayashi, and T. Katagiri
Microvolt T-Wave Alternans as a Predictor of Ventricular Tachyarrhythmias: A Prospective Study Using Atrial Pacing
Circulation,
April 20, 2004;
109(15):
1854 - 1858.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. R. Sipido
Understanding Cardiac Alternans: The Answer Lies in the Ca2+ Store
Circ. Res.,
March 19, 2004;
94(5):
570 - 572.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
B. D. Nearing and R. L. Verrier
Tracking cardiac electrical instability by computing interlead heterogeneity of T-wave morphology
J Appl Physiol,
December 1, 2003;
95(6):
2265 - 2272.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
D. S. Lee, L. D. Green, P. P. Liu, P. Dorian, D. M. Newman, F. C. Grant, J. V. Tu, and D. A. Alter
Effectiveness of implantable defibrillators for preventing arrhythmic events and death: A Meta-Analysis
J. Am. Coll. Cardiol.,
May 7, 2003;
41(9):
1573 - 1582.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. L Walker and D. S Rosenbaum
Repolarization alternans: implications for the mechanism and prevention of sudden cardiac death
Cardiovasc Res,
March 1, 2003;
57(3):
599 - 614.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
B. D. Nearing and R. L. Verrier
Progressive Increases in Complexity of T-Wave Oscillations Herald Ischemia-Induced Ventricular Fibrillation
Circ. Res.,
October 18, 2002;
91(8):
727 - 732.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. M. Narayan, F. Bode, P. L. Karasik, and M. R. Franz
Alternans of Atrial Action Potentials During Atrial Flutter as a Precursor to Atrial Fibrillation
Circulation,
October 8, 2002;
106(15):
1968 - 1973.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. A. Armoundas, G. F. Tomaselli, and H. D. Esperer
Pathophysiological basis and clinical application of T-wave alternans
J. Am. Coll. Cardiol.,
July 17, 2002;
40(2):
207 - 217.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
B. D. Nearing and R. L. Verrier
Modified moving average analysis of T-wave alternans to predict ventricular fibrillation with high accuracy
J Appl Physiol,
February 1, 2002;
92(2):
541 - 549.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. Klingenheben, G. Gronefeld, Y.-G. Li, and S. H. Hohnloser
Effect of metoprolol and d,l-sotalol on microvolt-level T-wave alternans: Results of a prospective, double-blind, randomized study
J. Am. Coll. Cardiol.,
December 1, 2001;
38(7):
2013 - 2019.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H. V. Barron
T-wave alternans and serious ventricular arrhythmias: a tale of two T-waves
J. Am. Coll. Cardiol.,
December 1, 2000;
36(7):
2254 - 2256.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E. J. Rashba, M. Cooklin, K. MacMurdy, N. Kavesh, M. Kirk, S. Sarang, R. W. Peters, S. R. Shorofsky, and M. R. Gold
Effects of Selective Autonomic Blockade on T-Wave Alternans in Humans
Circulation,
February 19, 2002;
105(7):
837 - 842.
[Abstract]
[Full Text]
[PDF]
|
 |
|
|